当前位置: X-MOL 学术Int. J. Biol. Sci. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
MicroRNA-4516 suppresses pancreatic cancer development via negatively regulating orthodenticle homeobox 1.
International Journal of Biological Sciences ( IF 9.2 ) Pub Date : 2020-05-18 , DOI: 10.7150/ijbs.45933
Shuo Chen 1 , Meng Xu 1 , Jing Zhao 2 , Jiaqi Shen 3 , Junhui Li 1 , Yang Liu 1 , Gang Cao 1 , Jiancang Ma 1 , Weizhou He 4 , Xi Chen 1 , Tao Shan 1
Affiliation  

Pancreatic cancer remains one of the most lethal human cancers without efficient therapeutic strategy. MicoRNAs (miRNAs) are a group of small non-coding RNAs involved in multiple biological processes including tumor development and progression. In this study, we investigated the expression and function of miR-4516 in pancreatic cancer. MiR-4516 was low-expressed in pancreatic cancer tissues and cell lines. Overexpression of miR-4516 inhibited pancreatic cancer cell proliferation, migration and invasion, while promoted cell apoptosis in vitro. Further, overexpression of miR-4516 suppressed xenograft pancreatic tumor growth in vivo. Bioinformatics analysis was performed and miR-4516 was predicted to negatively regulate orthodenticle homeobox 1 (OTX1) expression by binding to its 3'-UTR. Consistently, OTX1 was highly expressed in pancreatic cancer tissues and cell lines. Knockdown of OTX1 expression suppressed pancreatic cancer cell migration and invasion, with down-regulated MMP2 and MMP9 expression. Moreover, we demonstrated that miR-4516 regulated pancreatic cancer cell growth, migration, invasion and apoptosis via targeting OTX1. Overexpression of OTX1 could partially abrogate the inhibitory effect of miR-4516. Taken together, we conclude that miR-4516 could function as a tumor suppressor via targeting OTX1. These findings suggest that miR-4516/OTX1 axis might be a novel therapeutic target for miRNA-based therapy for pancreatic cancer patients.

中文翻译:

MicroRNA-4516 通过负调节正牙同源框 1 抑制胰腺癌的发展。

如果没有有效的治疗策略,胰腺癌仍然是最致命的人类癌症之一。MicoRNA (miRNA) 是一组小的非编码 RNA,参与包括肿瘤发展和进展在内的多种生物学过程。在这项研究中,我们研究了 miR-4516 在胰腺癌中的表达和功能。MiR-4516 在胰腺癌组织和细胞系中低表达。miR-4516的过表达抑制胰腺癌细胞增殖、迁移和侵袭,同时促进体外细胞凋亡。此外,miR-4516的过表达抑制了体内异种移植胰腺肿瘤的生长。进行了生物信息学分析,预测 miR-4516 通过与其 3'-UTR 结合来负调节正牙同源框 1 (OTX1) 的表达。一贯地,OTX1在胰腺癌组织和细胞系中高表达。敲低 OTX1 表达抑制胰腺癌细胞迁移和侵袭,下调 MMP2 和 MMP9 表达。此外,我们证明 miR-4516 通过靶向 OTX1 调节胰腺癌细胞的生长、迁移、侵袭和凋亡。OTX1 的过表达可以部分消除 miR-4516 的抑制作用。总之,我们得出结论,miR-4516 可以通过靶向 OTX1 作为肿瘤抑制因子。这些发现表明 miR-4516/OTX1 轴可能是胰腺癌患者基于 miRNA 的治疗的新治疗靶点。我们证明 miR-4516 通过靶向 OTX1 调节胰腺癌细胞的生长、迁移、侵袭和凋亡。OTX1 的过表达可以部分消除 miR-4516 的抑制作用。总之,我们得出结论,miR-4516 可以通过靶向 OTX1 作为肿瘤抑制因子。这些发现表明 miR-4516/OTX1 轴可能是胰腺癌患者基于 miRNA 的治疗的新治疗靶点。我们证明 miR-4516 通过靶向 OTX1 调节胰腺癌细胞的生长、迁移、侵袭和凋亡。OTX1 的过表达可以部分消除 miR-4516 的抑制作用。总之,我们得出结论,miR-4516 可以通过靶向 OTX1 作为肿瘤抑制因子。这些发现表明 miR-4516/OTX1 轴可能是胰腺癌患者基于 miRNA 的治疗的新治疗靶点。
更新日期:2020-05-18
down
wechat
bug